Your browser doesn't support javascript.
loading
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination.
Cheng, Samuel M S; Mok, Chris Ka Pun; Leung, Yonna W Y; Ng, Susanna S; Chan, Karl C K; Ko, Fanny W; Chen, Chunke; Yiu, Karen; Lam, Bosco H S; Lau, Eric H Y; Chan, Ken K P; Luk, Leo L H; Li, John K C; Tsang, Leo C H; Poon, Leo L M; Hui, David S C; Peiris, Malik.
Afiliação
  • Cheng SMS; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Mok CKP; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, P. R. China.
  • Leung YWY; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P. R. China.
  • Ng SS; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Chan KCK; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China.
  • Ko FW; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Chen C; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China.
  • Yiu K; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, P. R. China.
  • Lam BHS; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P. R. China.
  • Lau EHY; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China.
  • Chan KKP; Department of Pathology, North Lantau Hospital, Hong Kong, P. R. China.
  • Luk LLH; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Li JKC; Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, Hong Kong, P. R. China.
  • Tsang LCH; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China.
  • Poon LLM; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Hui DSC; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
  • Peiris M; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.
Nat Med ; 28(3): 486-489, 2022 03.
Article em En | MEDLINE | ID: mdl-35051989
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article